4
Changes in Ownership
Coherus Oncology, Inc. Filed Acc 0000899243-15-006181
Chief Scientific Officer sold 4,250 shares at an average $18.98 ($80,644)
- Chief Scientific Officer acquired 4,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Herman Alan C. · Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-10-01 | Exercise or conversion : show line 1 in the form | +4,250 | $0.42 | $1,771 | 218,949 | D |
| 2015-10-01 | Sale : show line 2 in the form | −3,350 | $18.83 | $63,089 | 215,599 | D |
| 2015-10-01 | Sale : show line 3 in the form | −900 | $19.51 | $17,555 | 214,699 | D |
| Open-market sales · 4,250 sh · avg $18.98 · $80,644 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2015-10-01 | Exercise or conversion : show line 4 in the form Stock Option (right to buy) | −4,250 | 75,777 | D |
Loading xslF345X03/doc4.xml…